You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Bortezomib monotherapy for relapsed multiple myeloma

  • Technology appraisal guidance
  • Reference number: TA129
  • Published:  23 October 2007
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders Appendix A: provisional matrix of stakeholders
05 March 2012
(122.02 Kb 35 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 02 March 2012

Back to top